Stocks and Investing Stocks and Investing
Mon, September 12, 2022
Fri, September 9, 2022
Thu, September 8, 2022
Wed, September 7, 2022

Serge Belanger Initiated (ARQT) at Strong Buy and Held Target at $46 on, Sep 7th, 2022


Published on 2024-10-27 22:55:40 - WOPRAI, Serge Belanger
  Print publication without navigation


Serge Belanger of Needham, Initiated "Arcutis Biotherapeutics, Inc." (ARQT) at Strong Buy and Held Target at $46 on, Sep 7th, 2022.

Serge has made no other calls on ARQT in the last 4 months.



There are 3 other peers that have a rating on ARQT. Out of the 3 peers that are also analyzing ARQT, 0 agree with Serge's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Serge


  • Jonathan Block of "Goldman Sachs" Maintained at Strong Buy with Increased Target to $50 on, Tuesday, August 2nd, 2022
  • Vikram Purohit of "Morgan Stanley" Maintained at Buy with Increased Target to $45 on, Tuesday, August 2nd, 2022
  • David Lebowitz of "Morgan Stanley" Maintained at Buy with Increased Target to $39 on, Tuesday, June 7th, 2022